Medication info
Candequr Tablet 16 mg (Candesartan Cilexetil)

Candequr Tablet 16 mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tablet
Manufacturer / importer
Teragen Etex Co., Ltd.
Appearance
Light yellow-pink, round, biconvex tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201903457 · Approved 2019.05.28 · Insurance code 671707190

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
Take this medicine at the same time every day, with or without food. 1. Essential hypertension Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. Elderly patients: No adjustment of the initial dose is necessary. Patients with intravascular volume depletion: For patients at increased risk of hypotension, such as those with reduced effective circulating blood volume, administer an initial dose of 4 mg with careful monitoring. Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. There is limited experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min). Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure Adults: An initial dose of 4 mg once daily is recommended. Double the dose at intervals of at least 2 weeks, and increase it to a maximum of 32 mg once daily according to the patient's tolerability. Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1. Essential hypertension: The safety and efficacy in adolescents and children aged 18 years or younger have not been established. 2. Heart failure: The safety and efficacy in adolescents and children aged 18 years or younger have not been established.

Ingredients

Manufacturer
Teragen Etex Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • left ventricular contractile dysfunction
  • decreased left ventricular ejection fraction
View approved original text

It is used for the treatment of essential hypertension and heart failure. For heart failure patients with impaired left ventricular contractility, it is especially applied when ACE inhibitors need to be added or are not well tolerated. This drug aids in improving hypertension and cardiac function.

How to take

Adult dose

Take this medicine at the same time every day, with or without food. 1. Essential hypertension Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. Elderly patients: No adjustment of the initial dose is necessary. Patients with intravascular volume depletion: For patients at increased risk of hypotension, such as those with reduced effective circulating blood volume, administer an initial dose of 4 mg with careful monitoring. Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. There is limited experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min). Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure Adults: An initial dose of 4 mg once daily is recommended. Double the dose at intervals of at least 2 weeks, and increase it to a maximum of 32 mg once daily according to the patient's tolerability. Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1. Essential hypertension: The safety and efficacy in adolescents and children aged 18 years or younger have not been established. 2. Heart failure: The safety and efficacy in adolescents and children aged 18 years or younger have not been established.

Precautions

This drug can cause serious harm to the fetus and newborn if taken during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergic reactions to this drug, severe liver impairment, or certain genetic disorders should not take this medication. Caution is required when using this drug in elderly patients, those with impaired kidney function, and those with low blood pressure, and it is especially important to regularly monitor serum potassium levels and kidney function. Some patients may experience side effects such as dizziness, back pain, and respiratory infections, and in severe cases, hypotension or kidney function impairment may occur. The blood pressure-lowering effect may be increased when this drug is used in conjunction with other antihypertensive agents. Particularly, caution should be taken when used with potassium-sparing diuretics or potassium supplements, as this may lead to dangerously high potassium levels in the blood. Breastfeeding women are advised to avoid this drug, and if it must be taken, breastfeeding should be discontinued. Caution is also advised when driving or operating machinery, as dizziness may occur. In case of overdose, symptoms such as symptomatic hypotension, dizziness, and rapid heartbeat may appear, and immediate medical treatment should be sought. The safety and efficacy of this drug in children and adolescents have not been established; therefore, it is recommended not to use it in individuals under 18 years of age.

Side effects

  • Dizziness
  • back pain
  • respiratory infection
  • weakness
  • fever
  • perception abnormality
  • dyspepsia
  • gastroenteritis
  • tachycardia
  • palpitations
Show 66 more
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • somnolence
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • hypotension
  • hyperkalemia
  • kidney function impairment
  • increased creatinine
  • increased urea
  • fatigue
  • peripheral edema
  • chest pain
  • headache
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • arthralgia
  • proteinuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • intestinal vascular edema
  • increased liver enzyme levels
  • hepatitis
  • elevated AST
  • elevated ALT
  • elevated γ-GTP
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disorders
  • decreased libido
  • amnesia
  • anorexia
  • increased appetite
  • tinnitus
  • taste disturbance
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. This helps to keep the medication effective for a longer time.

Appearance and packaging

Appearance

Light yellow-pink, round, biconvex tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.